Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NeuroBo Pharmaceuticals I...

    NASDAQ: NRBO · Real-Time Price · USD
    2.36
    null (null%)
    At close: Nov 27, 2024, 9:00 PM

    NeuroBo Pharmaceuticals Statistics

    Share Statistics

    NeuroBo Pharmaceuticals has 8.62M shares outstanding. The number of shares has increased by 51.98% in one year.

    Shares Outstanding

    n/a
    		 8.62M

    Shares Change (YoY)

    n/a
    		 51.98%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 4.59%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 34.27K, so 0.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 34.27K

    Short % of Shares Out

    n/a
    		 0.4%

    Short % of Float

    n/a
    		 1.06%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.5 and the forward PE ratio is null. NeuroBo Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.5

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.12

    P/FCF Ratio

    n/a
    		 -1.73

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    NeuroBo Pharmaceuticals has an Enterprise Value (EV) of -3.48M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 0.22

    EV / EBIT

    n/a
    		 0.32

    EV / FCF

    n/a
    		 0.32

    Financial Position

    The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.78

    Quick Ratio

    n/a
    		 3.78

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -74.74% and Return on Invested Capital is -94.83%.

    Return on Equity

    n/a
    		 -74.74%

    Return on Assets

    n/a
    		 -54.74%

    Return on Invested Capital

    n/a
    		 -94.83%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,558,750

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -0.28, so NeuroBo Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.28

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 2.49

    200-Day Moving Average

    n/a
    		 3.52

    Relative Strength Index (RSI)

    n/a
    		 26.03

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -15.89M

    Net Income

    n/a
    		 -12.47M

    EBITDA

    n/a
    		 -15.88M

    EBIT

    n/a
    		 -15.89M

    Earnings Per Share (EPS)

    n/a
    		 -2.46
    Full Income Statement

    Balance Sheet

    The company has 22.43M in cash and 203K in debt, giving a net cash position of 22.23M.

    Cash & Cash Equivalents

    n/a
    		 22.43M

    Total Debt

    n/a
    		 203K

    Net Cash

    n/a
    		 22.23M

    Retained Earnings

    n/a
    		 -108.27M

    Total Assets

    n/a
    		 22.15M

    Working Capital

    n/a
    		 12.82M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.8M and capital expenditures -50K, giving a free cash flow of -10.85M.

    Operating Cash Flow

    n/a
    		 -10.8M

    Capital Expenditures

    n/a
    		 -50K

    Free Cash Flow

    n/a
    		 -10.85M

    FCF Per Share

    n/a
    		 -2.14
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NRBO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -66.49%

    FCF Yield

    n/a
    		 -57.84%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NRBO.

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 21, 2023. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Dec 21, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -10.06

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist